The present study has several strengths: first, it analyzes the largest sample so far available investigating the association of PCSK9 with markers of subclinical atherosclerosis; second, it has been carried out in five European countries, thus increasing the results’ generalizability. The gene discussed is PCSK9; the disease is atherosclerosis.